Dose Reduction in Thoracic CT

This study has been completed.
Sponsor:
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00188461
First received: September 12, 2005
Last updated: April 20, 2007
Last verified: September 2005
  Purpose

Hypothesis: Does a 50% reduction in radiation in dose significantly affect the diagnostic quality of chest CT


Condition Intervention Phase
Lymphoma
Device: CT Thorax
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Dose Reduction in Thoracic CT: A Comparison of on Line Automatic Dose Reduction and a 50% Reduction in Dose

Resource links provided by NLM:


Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Evaluating the diagnostic quality of thoracic CT exams performed at 50% of standard dose parameters

Estimated Enrollment: 100
Study Start Date: January 2004
Estimated Study Completion Date: August 2005
Detailed Description:

Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the standard exposure parameters. The studies are compared for image quality with a recent (<3 months) thoracic CT performed at standard exposure parameters.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with Lymphoma

Exclusion Criteria:

  • No recent (<3 months) thoracic CT
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188461

Locations
Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00188461     History of Changes
Other Study ID Numbers: 03-0875
Study First Received: September 12, 2005
Last Updated: April 20, 2007
Health Authority: Canada: Health Canada

ClinicalTrials.gov processed this record on October 01, 2014